UW bioengineers from Suzie Pun's lab, along with collaborators from Emergency Medicine and Chemical Engineering, have developed an injectable polymer that could keep soldiers and trauma patients from bleeding to death.
Dr. Buddy D. Ratner, UW joint professor of bioengineering and chemical engineering and Michael L. & Myrna Darland Endowed Chair in Technology Commercialization, was honored with the second-ever UW Medicine Lifetime Innovator Award on November 6. He received the award at UW Medicine's 2014 Inventor of the Year event held at UW Medicine's South Lake Union campus.
UW Bioengineering Professor Dr. Valerie Daggett and research team members have designed a peptide structure that can stop harmful changes of proteins in the body that are linked to diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease (ALS).
UW Bioengineering faculty Charles Murry (joint professor of pathology, bioengineering and medicine/cardiology) and Michael Regnier, as well as adjunct faculty Michael Jensen, MD, director of the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute and professor of pediatric hematology-oncology at UW Medicine and Satoshi Minoshima, professor of radiology, were named 2014 UW Presidential Entrepreneurial Faculty Fellows.
UW Bioengineering Ph.D. student, Cameron Ball, and Assistant Professor Kim Woodrow, demonstrate the potential of a new type of product that may help women protect themselves against sexual HIV transmission. Their research, published online ahead of print in the journal Antimicrobial Agents and Chemotherapy (AAC) of the American Society for Microbiology, shows the ability of water-soluble electrospun fiber material to rapidly release maraviroc, an antiretroviral drug. The researchers suggest that their material offers advantages over other anti-HIV microbicides currently in development.
Stem cell therapy regenerates heart muscle in primates, finds a study led by Dr. Charles Murry, UW professor of pathology, bioengineering and cardiology. This approach, which uses heart cells created from human embryonic stem cells, should be feasible in humans and may be ready for clinical trials in humans within four years, researchers say. The study was published in the advanced online April 30, 2014 edition of Nature.
UW Bioengineering professor Dr. Charles Murry (joint in Cardiology and Pathology) and adjunct faculty Dr. François Baneyx (professor of Chemical Engineering) are among 5 UW faculty members recently named American Association for the Advancement of Science (AAAS) Fellows.
UW Bioengineering professors David Castner, Paul Yager and Patrick Stayton named to Washington State Academy of Sciences.
UW Bioengineering professor Dr. Buddy Ratner has developed a biomaterial that resists the body's natural [...]